12:00 AM
 | 
Dec 04, 2000
 |  BC Week In Review  |  Company News  |  Deals

Interleukin Genetics, Kenna Technologies Inc. deal

Kenna acquired a non-exclusive worldwide license to commercialize ILGN's BioFusion biological disease modeling software that models...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >